header-news

Latest News

Aspen to distribute Merck products

October 7, 2010

Effective immediately, Aspen is taking over the sales, distribution and marketing of a portfolio of dermatology products from Merck, with estimated annual sales of $50 million.

Read More >>

Stephen Saad, CEO of Aspen Holdings, comments on Sigma purchase

August 17, 2010

An interview of Stephen Saad, CEO of Aspen Holdings.

Read More >>

Aspen Announcement to JSE

August 16, 2010

Announcement regarding the acquisition of the pharmaceutical business of Sigma Pharmaceuticals Limited by Aspen.

Read More >>

Aspen make a bid for Sigma

May 24, 2010

Aspen shareholders are advised that Aspen has submitted an indicative non-binding proposal to acquire, either directly or through a wholly-owned subsidiary, Sigma Pharmaceuticals Limited.

Read More >>

Aspen and GSK Agree On Series Of Strategic Transactions

May 13, 2009

Aspen, Africa’s largest pharmaceutical manufacturer, has announced that it has agreed to multiple, strategic, inter-dependent transactions with a leading multinational pharmaceutical group, GlaxoSmithKline.

Read More >>

Diversity and Flexibility eNews

April 29, 2009

Aspen’s high level of flexibility has shown demonstrable business outcomes in addition to the attraction/retention of diverse talent, including consistently meeting sales objectives and extremely high value customer relationships.

Read More >>

Aspen take on Tritace and Cardizem

March 6, 2008

Aspen Pharmacare have signed a licensing agreement with Sanofi-Aventis for the distribution, sales and marketing of Tritace and Cardizem.

Read More >>

Aspen form alliance with Actavis

March 6, 2008

Aspen Australia have signed a license agreement with Actavis, taking on the sales, marketing and distribution of two products, Neotigason and Rapilysin.

Read More >>